News
Novo Nordisk Offers Ozempic at $499 Per Month to Eligible US Cash-Paying Customers
(Reuters) -Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients with type 2 diabetes in the U.S. via its own pharmacy, a tie-up with telehealth service GoodRx and other platforms.
The maker of Ozempic is cutting the price of the drug nearly in half for some patients. Novo Nordisk had already cut the ...
The Little Mix singer said she auditioned for "The X Factor" just months after leaving the hospital, where she was treated ...
Reports are emerging of women experiencing changes in their genital area, dubbed 'Ozempic vulva,' linked to rapid weight loss ...
CafeMom on MSN10h
Women Now Warning of ‘Ozempic Vulva’ After Using the Drug for Weight Loss - Here’s What To Know
They can occur whenever someone loses a significant amount of weight over a short period of time. Like “Ozempic face,” ...
Fact checked by Nick Blackmer With anti-obesity medications like Ozempic, Wegovy, and Zepbound exploding in popularity in ...
Ozempic faces over 1,800 lawsuits in US courts, with damages possibly topping $2 billion. Patients allege the drug caused ...
After ‘Ozempic face’ and ‘Ozempic hands’, a new term is making rounds on social media — ‘Ozempic vulva’. The phrase is not a ...
NAION is a rare form of vision loss that’s been linked to semaglutide, the active ingredient in Wegovy and Ozempic.
Green Matters on MSN7h
Ozempic Sparks Both Weight Loss Success Stories and Major Lawsuits in 2025
The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback